While skill and hard work drove development, AstraZeneca said it was a minor mistake that made the team realise how they could significantly boost the shot's success rate, to as much as 90% from around 60%: by administering a half dose, followed by a full dose a month later.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3pVieE6
via IFTTT
0 comments:
Post a Comment